LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/NASS Seeks Allograft and Spinal Stim Comments by May 20
Spine

NASS Seeks Allograft and Spinal Stim Comments by May 20

May 5, 2017 2 min read Premium comments

Advertisement

NASS Seeks Allograft and Spinal Stim Comments by May 20
Source: North American Spine Society
Secondary

Surgeons…time to opine on new coverage recommendations from the North American Spine Society (NASS). You have until May 20, 2017 to comment on Allograft and Demineralized Bone Matrix for Spinal Fusion and Spinal Cord Stimulation.

John A. Glaser, M.D., co-chair of the NASS Coverage Committee and orthopedic surgeon with the Medical University of South Carolina told OTW, “The goal of the NASS Coverage Recommendations is to ensure that patients continue to have access to appropriate quality spine care. As with many of our topics, the debates on these two recently published topics centered around the strength of existing evidence.”

“We would love to have plentiful, very high-level evidence for every topic but that may not be possible in each situation. After an exhaustive review of what can sometimes be hundreds of scientific articles, the members of the NASS Coverage team work together to develop its recommendations. In the absence of high-level data, NASS recommendations reflect the multi-disciplinary experience and expertise of the committee members in order to present reasonable standard practice indications in the United States.”

Asked what they hope will come from the 30-day comment period, he noted, “As an organization, NASS strives for increased collaboration between all interested parties and greater transparency to address important topics which may not yet have high-level evidence.”

“This public comment period is an opportunity for both NASS and interested parties to proactively discuss and develop appropriate indications for common spine care treatments and procedures. In the past, we received constructive feedback on various topics and this additional step of hosting a public comment period has helped us better address the needs of our members and the millions of patients we serve. We hope this 30-day comment period will provide an opportunity and time for subject-matter experts and interested parties to review NASS’ proposed recommendations and make us aware of any important literature that we may have missed during our preliminary review.”

As for his message to spine surgeons, Dr. Glaser told OTW, “Patients rely upon their spine care specialists for the most appropriate and cost-effective treatment options. To provide these specialists with the most current evidence-based recommendations, it is critical that the spine care community works together. We encourage you to share your expertise with NASS by participating in these public comment periods.”

Please click here to access NASS’ draft coverage recommendations for Allograft and Demineralized Bone Matrix for Spinal Fusion and Spinal Cord Stimulation. Your comments can be shared with the committee via coverage@spine.org.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy